In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

Investigators developed an in vivo CAR T cell engineering platform to streamline production while using mRNA to induce transient, tunable CAR expression.